High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome

類似資料

• Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer
  著者:: Somlo, G, 等
  出版事項: (2002)
• Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer
  著者:: Burnell, Margot, 等
  出版事項: (2010)
• Long-Term Survival after High-Dose Chemotherapy Followed by Peripheral Stem Cell Rescue for High-Risk, Locally Advanced/Inflammatory, and Metastatic Breast Cancer
  著者:: VanderWalde, A., 等
  出版事項: (2012)
• Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study
  著者:: Vaz-Luis, Ines, 等
  出版事項: (2020)
• High dose, dose-intensive chemotherapy with doxorubicin and cyclophosphamide for the treatment of advanced breast cancer.
  著者:: Ferguson, J. E., 等
  出版事項: (1993)